Using prognostic models to improve the quality of care for patients with chronic kidney disease in primary care settings

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Determination of the clinical significance of current prognostic models (using the Cox prognostic model as an example) and their use in practical healthcare to improve the life expectancy and quality of life of patients with chronic kidney disease (CKD).

Materials and methods. The study analyzed clinical and laboratory data from 70 CKD patients in the Internal Medicine Department of a City Outpatient Clinic in the Tyumen region. Clinical, laboratory, and instrumental parameters were assessed. indicators that predict CKD progression were calculated, followed by the formation of the Cox prognostic model.

Results. Using the Cox prognostic model, groups of CKD patients with low, moderate, and high risk of disease progression were identified, which is a more accurate prognostic method compared to routine patient questionnaires. The prognostic model, using statistically reliable criteria, demonstrated its effectiveness and utility in healthcare practice for assessing the rate of CKD progression.

Conclusion. Adapting the Cox model for outpatient practice is an important step toward improving the quality of CKD patient monitoring.

About the authors

Vladimir A. Zhmurov

Tyumen Medical University

Author for correspondence.
Email: zhmdenis@yandex.ru

Dr.Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal Medicine

Russian Federation, Tyumen

Polina A. Ermakova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Teaching Assistant, Department of Propaedeutics of Internal Medicine

Russian Federation, Tyumen

Anna A. Ermakova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Teaching Assistant, Department of Propaedeutics of Internal Medicine

Russian Federation, Tyumen

Denis V. Zhmurov

Tyumen Medical University

Email: zhmdenis@yandex.ru

Cand.Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Medicine

Russian Federation, Tyumen

Natalya V. Tolstoukhova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Cand.Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Medicine

Russian Federation, Tyumen

References

  1. Collins G.S., Moons K.G.M. Reporting of Prediction Models in Primary Care: Transparent Reporting Is Needed. Br. J. General Pract. 2019;69(686):435–7.
  2. Романова Т.Е., Абаева О.П., Романов С.В., Родина А.А. Отношение пациентов многопрофильного стационара к процессам цифровизации в современном здравоохранении: одномоментное сплошное исследование. Социология медицины. 2022;21(2):177–81. [Romanova T.E., Abaeva O.P., Romanov S.V., Rodina A.A. Attitude of patients of a multidisciplinary hospital towards digitalization processes in modern healthcare: a cross-sectional continuous study. Sociology of Medicine. 2022;21(2):177–81. (In Russ.)].
  3. Харламов А.В. Анализ рисков применения прогностических моделей. Математическое и компьютерное моделирование в экономике, страховании и управлении рисками. 2021;6:164–8. [Kharlamov A.V. Risk analysis of predictive models application. Mathematical and computer modeling in economics, insurance, and risk management. 2021; 6:164–8 (In Russ.)].
  4. Лучинин А.С. Прогностические модели в медицине. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2023;16(1):27–36. [Luchinin A.S. Prognostic models in medicine. Clinical oncohematology. Fundamental research and clinical practice. 2023;16(1):27–36 (In Russ.)].
  5. Габаев М.И. Хроническая болезнь почек. Влияние нефропротективной терапии на качество жизни пациентов в контексте стандартизации системы здравоохранения. Проблемы стандартизации в здравоохранении. 2019;5–6:58–62. [Gabaev M.I. Chronic kidney disease. The impact of nephroprotective therapy on patients’ quality of life in the context of healthcare system standardization. Problems of standardization in healthcare. 2019; 5–6: 58–62 (In Russ.)].
  6. Мацкевич С.А. Хроническая болезнь почек: кардиоренальные взаимоотношения. Лечебное дело. 2017;1:4–10. [Matskevich S.A. Chronic kidney disease: cardiorenal relationships. General Medicine. 2017;1:4–10 (In Russ.)].
  7. Батюшин М.М. Хроническая болезнь почек: современное состояние проблемы. Рациональная фармакотерапия в кардиологии. 2020;16(6):938–47. doi: 10.20996/1819-6446-2020-11-06. [Batyushin M.M. Chronic kidney disease: current state of the problem. Rational pharmacotherapy in cardiology. 2020;16(6):938–47. doi: 10.20996/1819-6446-2020-11-06 (In Russ.)].
  8. Даминова К.М. и др. Особенности ранней диагностики хронической болезни почек. Innovative developments and research in education. 2023;2(13):179–86. [Daminova K.M. et al. Features of early diagnosis of chronic kidney disease. Innovative developments and research in education. 2023;2(13):179–86 (In Russ.)].
  9. Муркамилов И.Т. и др. Современные методы замедления прогрессирования хронической болезни почек при сахарном диабете II типа. Вестник современной клинической медицины. 2020;13(4):76–85. doi: 10.20969/VSKM.2020.13(4).76-85. [Murkamilov I.T. et al. Modern methods for slowing the progression of chronic kidney disease in type II diabetes mellitus. Bulletin of Modern Clinical Medicine. 2020;13(4):76–85. doi: 10.20969/VSKM.2020.13(4).76-85 (In Russ.)].
  10. Шамхалова М.Ш. и др. Хроническая болезнь почек у пациентов с сахарным диабетом: новые вызовы. Сахарный диабет. 2025;28(1):49–58. [Shamkhalova M.Sh. et al. Chronic kidney disease in patients with diabetes mellitus: new challenges. Diabetes mellitus. 2025;28(1):49–58 (In Russ.)].
  11. Жмуров В.А., Ермакова П.А., Ермакова А.А. и др. Оценка эффективности нефропротективной терапии у пациентов с хронической болезнью почек и артериальной гипертензией. Клиническая нефрология. 2024;16(3):26–30. [Zhmurov V.A., Ermakova P.A., Ermakova A.A., et al. Evaluation of the effectiveness of nephroprotective therapy in patients with chronic kidney disease and arterial hypertension. Clinical nephrology. 2024;16(3):26–30 (In Russ.)].
  12. Medsoftpro URL: https://medsoftpro.ru/kalkulyatory/charlson-comorbidity-index.html (date of access – 12.01.2026).
  13. GeeksforGeeks. URL: https://www.geeksforgeeks.org/data-science/ cox-regression/(date of access – 12.01.2026).
  14. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care. 1986;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
  15. Analytics. URL: https://4analytics.ru/metodi-analiza/mape-srednyaya-absolyutnaya-oshibka-praktika-primeneniya.html (date of access – 12.01.2026).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 Bionika Media